Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-028195
Filing Date
2019-05-24
Accepted
2019-05-24 17:00:23
Documents
2
Period of Report
2019-05-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv522431_4.html 4  
1 OWNERSHIP DOCUMENT tv522431_4.xml 4 4183
2 EXHIBIT 24 tv522431_ex24.htm EX-24 5621
  Complete submission text file 0001144204-19-028195.txt   11175
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Issuer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2575 W. BELLFORT SUITE 333 HOUSTON TX 77054
Business Address
George Robert E. (Reporting) CIK: 0001674701 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37758 | Film No.: 19855148